DE60118955D1 - Farnesyltransferase inhibitoren - Google Patents

Farnesyltransferase inhibitoren

Info

Publication number
DE60118955D1
DE60118955D1 DE60118955T DE60118955T DE60118955D1 DE 60118955 D1 DE60118955 D1 DE 60118955D1 DE 60118955 T DE60118955 T DE 60118955T DE 60118955 T DE60118955 T DE 60118955T DE 60118955 D1 DE60118955 D1 DE 60118955D1
Authority
DE
Germany
Prior art keywords
transferase inhibitors
farnesyl transferase
farnesyl
inhibitors
transferase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60118955T
Other languages
English (en)
Other versions
DE60118955T2 (de
Inventor
K Claiborne
L Gwaltney
A Hasvold
Qun Li
Tomgmei Li
Nan-Horng Lin
A Mantei
W Rockway
L Sham
M Sullivan
Yunsong Tong
T Wang
Le Wang
Xilu Wang
Weibo Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Application granted granted Critical
Publication of DE60118955D1 publication Critical patent/DE60118955D1/de
Publication of DE60118955T2 publication Critical patent/DE60118955T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
DE60118955T 2000-11-30 2001-11-30 Farnesyltransferase inhibitoren Expired - Fee Related DE60118955T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US72723000A 2000-11-30 2000-11-30
US727230 2000-11-30
US912677 2001-07-25
US09/912,677 US20020115640A1 (en) 2000-11-30 2001-07-25 Farnesyltransferase inhibitors
PCT/US2001/043168 WO2002074747A1 (en) 2000-11-30 2001-11-30 Farnesyltransferase inhibitors

Publications (2)

Publication Number Publication Date
DE60118955D1 true DE60118955D1 (de) 2006-05-24
DE60118955T2 DE60118955T2 (de) 2007-01-04

Family

ID=24921844

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60118955T Expired - Fee Related DE60118955T2 (de) 2000-11-30 2001-11-30 Farnesyltransferase inhibitoren

Country Status (31)

Country Link
US (1) US20020115640A1 (de)
EP (1) EP1339695B1 (de)
JP (1) JP2004519503A (de)
KR (1) KR20030060968A (de)
CN (1) CN1487924A (de)
AR (1) AR035375A1 (de)
AT (1) ATE323681T1 (de)
BG (1) BG107908A (de)
BR (1) BR0112028A (de)
CA (1) CA2430619A1 (de)
CY (1) CY1106104T1 (de)
CZ (1) CZ20031804A3 (de)
DE (1) DE60118955T2 (de)
DK (1) DK1339695T3 (de)
EC (1) ECSP034634A (de)
ES (1) ES2261340T3 (de)
HK (1) HK1059260A1 (de)
HU (1) HUP0600331A2 (de)
IL (2) IL156212A0 (de)
MX (1) MXPA03004879A (de)
MY (1) MY136181A (de)
NO (1) NO20032471L (de)
NZ (1) NZ526313A (de)
PE (1) PE20020687A1 (de)
PL (1) PL363637A1 (de)
PT (1) PT1339695E (de)
SA (1) SA01220565B1 (de)
SI (1) SI1339695T1 (de)
SK (1) SK286686B6 (de)
UY (1) UY27046A1 (de)
WO (1) WO2002074747A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006116716A2 (en) * 2005-04-27 2006-11-02 University Of Florida Materials and methods for enhanced degradation of mutant proteins associated with human disease
JP4592548B2 (ja) * 2005-08-24 2010-12-01 株式会社エヌ・ティ・ティ・ドコモ 送信電力制御方法及び移動通信システム
US7722316B2 (en) * 2005-09-13 2010-05-25 Rolls-Royce Power Engineering Plc Acoustic viscous damper for centrifugal gas compressor
US7790770B2 (en) 2005-11-23 2010-09-07 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
TW200806284A (en) * 2006-03-31 2008-02-01 Alcon Mfg Ltd Prenyltransferase inhibitors for ocular hypertension control and the treatment of glaucoma
US8084477B2 (en) * 2007-10-31 2011-12-27 Bristol-Myers Squibb Company Alpha-(N-sulfonamido)acetamide compound as an inhibitor of beta amyloid peptide production
US20110086834A1 (en) * 2008-06-26 2011-04-14 Amgen Inc. Alkynyl alcohols as kinase inhibitors
US20130324521A1 (en) * 2010-11-26 2013-12-05 Reza Ghotbi Implant for treating or preventing an aneurysm
CN105693617B (zh) * 2014-11-24 2018-06-08 中国科学院大连化学物理研究所 一种tmsn3参与的还原环化反应制备4-咪唑甲醛衍生物的方法
US10177604B2 (en) 2015-10-07 2019-01-08 Tc1 Llc Resonant power transfer systems having efficiency optimization based on receiver impedance
CN112851508A (zh) * 2019-11-27 2021-05-28 广东东阳光药业有限公司 一种巴洛沙韦中间体的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU706150B2 (en) * 1996-04-03 1999-06-10 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US6297239B1 (en) * 1997-10-08 2001-10-02 Merck & Co., Inc. Inhibitors of prenyl-protein transferase
CA2341739C (en) * 1998-08-27 2005-07-12 Pfizer Products Inc. Quinolin-2-one derivatives useful as anticancer agents

Also Published As

Publication number Publication date
CN1487924A (zh) 2004-04-07
NO20032471D0 (no) 2003-05-30
UY27046A1 (es) 2002-07-31
EP1339695A1 (de) 2003-09-03
SA01220565B1 (ar) 2007-01-27
MXPA03004879A (es) 2004-05-04
PT1339695E (pt) 2006-08-31
NZ526313A (en) 2004-11-26
SK8232003A3 (en) 2004-01-08
NO20032471L (no) 2003-07-25
CA2430619A1 (en) 2002-09-26
WO2002074747A1 (en) 2002-09-26
ES2261340T3 (es) 2006-11-16
SK286686B6 (sk) 2009-03-05
HK1059260A1 (en) 2004-06-25
ECSP034634A (es) 2003-07-25
DE60118955T2 (de) 2007-01-04
KR20030060968A (ko) 2003-07-16
ATE323681T1 (de) 2006-05-15
CZ20031804A3 (cs) 2003-11-12
MY136181A (en) 2008-08-29
BR0112028A (pt) 2004-02-17
EP1339695B1 (de) 2006-04-19
PL363637A1 (en) 2004-11-29
IL156212A (en) 2008-11-26
IL156212A0 (en) 2003-12-23
US20020115640A1 (en) 2002-08-22
BG107908A (bg) 2004-01-30
SI1339695T1 (sl) 2006-10-31
AR035375A1 (es) 2004-05-12
DK1339695T3 (da) 2006-07-31
CY1106104T1 (el) 2011-06-08
PE20020687A1 (es) 2002-08-03
JP2004519503A (ja) 2004-07-02
HUP0600331A2 (en) 2006-10-28

Similar Documents

Publication Publication Date Title
ATE524441T1 (de) Vla-4-inhibitoren
NO20034042L (no) Metallproteinase-inhibitorer
DE60211317D1 (de) Rho-kinase inhibitoren
DE60218138D1 (de) Rho-kinase inhibitoren
DK1255544T3 (da) Mucin-syntese-inhibitorer
NO20034032D0 (no) Metallproteinase-inhibitorer
DK1272488T3 (da) Tri-aryl-substitueret ethan-PDE4-inhibitorer
ATE293622T1 (de) Farnesyl protein transferase inhibitoren
AU2001252147A1 (en) Farnesyl protein transferase inhibitor combinations
ATE323681T1 (de) Farnesyltransferase inhibitoren
ID29320A (id) Fluida-fluida kental bebas padatan
HK1053833A1 (zh) 取代苯基法呢基轉移酶抑制劑
DE60025650D1 (de) Farnesyltransferase inhibitoren
DK1130214T3 (da) Korrosionsinhibitorer
AR028075A1 (es) Inhibidores de la peptido-desformilasa
AU3514302A (en) 0ovel farnesyl protein transferase inhibitors
ATE323096T1 (de) Prenyltransferase-inhibitoren
DE50113683D1 (de) Querträger
DK1296985T3 (da) Heteropolycykliske inhibitorer

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee